Neuspera Medical, Inc.
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. The company’s proprietary Mid-Field Powering Technology allows devices to be significantly smaller, implanted deeper, and more reliable than other miniaturized neuromodulation technologies. The Neuspera platform will provide patients and physicians new, and potentially earlier, treatment options that are less invasive and more adaptable. These therapeutic alternatives may help patients restore their health and well-being for a better quality of life.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
About Us
Urinary urgency incontinence
The Neuspera Implantable Sacral Neuromodulation (SNM) System is comprised of a minimally-invasive implant and convenient external wearable designed to provide relief from the life-limiting symptoms of UUI
Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera’s minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.
Our Values
SMALLER. DEEPER. SMARTER
The Neuspera system provides a flexible treatment approach that allows neuromodulation therapy to be administered according to a patient’s needs, while preserving other treatment options. Our procedure uses standard tools and current SNM implantation techniques. Repeat surgeries to replace batteries are not needed.